Gerresheimer AG
XETRA:GXI

Watchlist Manager
Gerresheimer AG Logo
Gerresheimer AG
XETRA:GXI
Watchlist
Price: 70 EUR 3.47% Market Closed
Market Cap: 2.4B EUR
Have any thoughts about
Gerresheimer AG?
Write Note

Operating Margin
Gerresheimer AG

10.2%
Current
10%
Average
3.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.2%
=
Operating Profit
205m
/
Revenue
2B

Operating Margin Across Competitors

Country DE
Market Cap 2.4B EUR
Operating Margin
10%
Country US
Market Cap 1.2T USD
Operating Margin
14%
Country US
Market Cap 201B USD
Operating Margin
17%
Country US
Market Cap 166.8B USD
Operating Margin
21%
Country KR
Market Cap 66.7T KRW
Operating Margin
31%
Country CH
Market Cap 38.4B CHF
Operating Margin
13%
Country US
Market Cap 38.7B USD
Operating Margin
24%
Country US
Market Cap 36.3B USD
Operating Margin
14%
Country US
Market Cap 27B USD
Operating Margin
28%
Country US
Market Cap 24.1B USD
Operating Margin
20%
Country US
Market Cap 22.2B USD
Operating Margin
29%
No Stocks Found

Gerresheimer AG
Glance View

Market Cap
2.4B EUR
Industry
Life Sciences Tools & Services

Gerresheimer AG, nestled in the heart of Germany, has evolved into a cornerstone of the pharmaceutical and healthcare industries. Its beginnings were humble, rooted in glass manufacturing over a century ago, but the company has since metamorphosed into a leading provider of specialized products for the global healthcare market. Today, Gerresheimer's portfolio stretches well beyond glass, encompassing a range of highly technical and innovative products. The company specializes in producing glass and plastic containers, including vials, ampoules, and cartridges, which are crucial for delivering drugs and vaccines safely to patients worldwide. Its sophisticated offerings extend to complex drug delivery devices like insulin pens and inhalers, showcasing its deep integration into the supply chains of major pharmaceutical companies. Gerresheimer's business model thrives on close partnerships with these pharmaceutical giants, crafting tailor-made solutions for diverse therapeutic areas. This strategic alignment positions it well amid growing global health needs and an aging population, driving steady demand for its high-margin products. Its operations are bolstered by an international footprint of production facilities, allowing for high-quality, efficient manufacturing and distribution. This network not only enhances its logistics but also supports the company's commitment to innovation, enabling it to meet specific regulatory and market requirements across different regions. Ultimately, Gerresheimer AG makes its mark and profits through a combination of cutting-edge technology, stringent quality standards, and strategic relationships, securing its place as a vital player in the global healthcare ecosystem.

GXI Intrinsic Value
153.03 EUR
Undervaluation 54%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.2%
=
Operating Profit
205m
/
Revenue
2B
What is the Operating Margin of Gerresheimer AG?

Based on Gerresheimer AG's most recent financial statements, the company has Operating Margin of 10.2%.